Hitting the Right Spot: Advances in the Treatment of NSCLC with Uncommon EGFR Mutations
Meeting Host
Description
The Georgia Society of Clinical Oncology (GASCO) cordially invites you to attend an ACCME/ANCC/ ABIM MOC-certified, live webinar entitled, Hitting the Right Spot: Advances in the Treatment of NSCLC with Uncommon EGFR Mutations, held live online! This activity will provide oncology clinicians with information on the biology and challenges associated with uncommon EGFR mutations, the latest guidance on identifying patients with these mutations, and safety and efficacy data for novel treatment options for patients who carry these mutations.
When
Date: Tuesday, November 2, 2021
Time: 5:30 p.m. - 6:30 p.m. Eastern Time
Registration
For full accreditation information and to register, visit www.rockpointe.com/GASCO-Registration.
Meeting Details
Program Faculty
Joshua K. Sabari, MD
Assistant Professor of Medicine, Department of Medical Oncology
NYU Langone Health Perlmutter Cancer Center
New York, NY
Physician Accredidation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation Statement
USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™;. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Accredidation and Designation Statement
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.0 contact hours may be earned by learners who successfully complete this continuing professional development activity. USF Health, the accredited provider, acknowledges Rockpointe as the joint provider in the planning and execution of this CNE activity.
This activity is awarded 1.0 ANCC pharmacotherapeutic contact hours.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Fee and Receiving CME Credit
There is no fee for this activity. To receive credit, participants must register, view the live CE activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.
Disclosures will be made known to participants before the activity.
Jointly provided by USFH and Rockpointe
In collaboration with the American Lung Association
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Takeda Oncology.
